Juno Therapeutics and Editas Medicine Collaborate to Develop Next-Generation CAR-T Therapeutics Using CRISPR/Cas9 |
Abstract
|
Heather Cartwright & Keshav Mahawar |
|
Achillion Disappoints Investors by Partnering HCV Assets with Janssen |
Abstract
|
Heather Cartwright & Shruti Desai |
|
Endo to Acquire Par Pharma for US$8.05 B to Become Top 5 US Generics Company |
Abstract
|
Heather Cartwright & Rohit Khera |
|
NantPharma to Acquire Third-Generation Paclitaxel from Sorrento Therapeutics in Potential US$1.3 B Deal |
Abstract
|
Heather Cartwright & Tridisha Goswami |
|